This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pasquali, R. Articles by Vettor, R. Search for Related Content PubMed PubMed Citation Articles by Pasquali, R. Articles by Vettor, R.

Cortisol and ACTH Response to Oral Dexamethasone in Obesity and Effects of Sex, Body Fat Distribution, and Dexamethasone Concentrations: A Dose-Response Study

Department of Internal Medicine (R.P.), Endocrinology Unit, University of Bologna, I-40100 Bologna, Italy; Institute of Endocrine Sciences, Inc. (B.A.), University of Milan, I-20100 Milan, Italy; Department of Medical and Surgical Sciences (D.A., F.M.), Endocrinology Unit, University of Padua, I-35100 Padua, Italy; Endocrinology Unit (F.C.), IRCCS San Luca Hospital, University of Milan, I-20100 Milan, Italy; Endocrinology Section (E.D.U.), University of Ferrara, I-44100 Ferrara, Italy; Endocrinology Service (G.D.R.), University of Modena, I-41100 Modena, Italy; DETO (G.D.P.), University of Bari, I-70100 Bari, Italy; Division of Endocrinology (M.Mac.), University of Turin, I-10100 Turin, Italy; Galliera Hospital (M.Mar.), Genoa, I-15100 Genoa, Italy; Department of Clinical Physiopathology (C.M.R.), Endocrinology Section, University of Florence, I-50100 Florence, Italy; Institute of Medical Semeiotic (R.V.), University of Padua, I-35100 Padua, Italy

Address all correspondence and requests for reprints to: Renato Pasquali, M.D., U. O. di Endocrinologia, Dipartimento di Medicina Interna, Ospedale S. Orsola, Via Massarenti 9, 40138, Bologna, Italy. E-mail: rpasqual{at}almadns.unibo.it

There is increasing evidence that the abdominal obesity phenotype may be associated with multiple alterations of the hypothalamic-pituitary-adrenocortical (HPA) axis activity in both sexes. Our hypothesis is that the lack of adequate cortisol suppression after the dexamethasone test may constitute an indirect marker of HPA axis hyperactivity in the presence of the abdominal obesity phenotype. A total of 34 normal-weight (13 men and 21 women) and 87 obese (36 men and 51 women), healthy, nondepressed subjects therefore underwent four different dexamethasone suppression tests randomly performed at varying intervals of at least 1 wk between each test. After a standard overnight 1-mg dexamethasone test, which served as a reference, three other tests were randomly performed at 1-wk intervals by administering 0.0035, 0.0070, and 0.015 mg oral dexamethasone per kilogram of body weight overnight. Blood samples were obtained for cortisol, ACTH, and dexamethasone. Results were analyzed separately in men and women as well as in normal-weight [body mass index (BMI) 25 kg/m²] and overweight or obese (BMI >25 kg/m²) subjects. The waist circumference and the waist to hip ratio (WHR) were used as markers of body fat distribution. After the standard 1-mg test, cortisol suppression was greater than 90% in all subjects. However, after each test, obese women had significantly higher values of percent cortisol and percent ACTH suppression than normal-weight women without any difference between obese and normal-weight men. Considering the response to the three variable-dose tests, a clear dose- response pattern (P < 0.001 for trend analysis) in percent cortisol and percent ACTH suppression was found in all subjects. After each test men had significantly higher dexamethasone levels than women, regardless of BMI. However, obese women, but not men, had significantly higher dexamethasone levels after each test than their normal-weight counterpart. Plasma dexamethasone concentrations were dose related (P < 0.001 for trend analysis) in all subjects, but the dose-related increase was significantly higher in normal-weight men than normal-weight women, whereas it was similar in obese subjects of both sexes. Stepwise multiple regression analysis revealed that both percent cortisol and percent ACTH variations were significantly and negatively influenced by dexamethasone levels, as well as by waist circumference values in men, and independently by BMI and waist circumference in women. However, in contrast to what has been found in men, a divergent contribution of BMI and waist circumference was found in women indicating that, with increasing waist values, a smaller suppression of the HPA axis was found with respect to that expected on the basis of BMI values. In conclusion, this study provides data of both physiological and physiopathological relevance. Overall, our data indicated that adjustment of the dexamethasone dose to body weight does not seem to substantially improve the sensitivity of the test, even in obese individuals, particularly when near-maximal doses are administered. However, this study demonstrated a highly significant effect of dexamethasone blood level concentrations on cortisol and ACTH suppression to low-dose dexamethasone tests. In addition, a significant effect of gender on postdexamethasone cortisol concentrations, suppression of the HPA axis, and dexamethasone levels were found, which may be dependent on related differences in both cortisol and dexamethasone metabolism. We showed that pituitary sensitivity to feedback inhibition by dexamethasone is preserved in obesity in both sexes even at low dosages. On the other hand, our data suggest that, at least in women, abdominal fat distribution may partially counteract the progressively greater suppressibility of the HPA axis that would be expected according to increasing BMI.

This work was supported by the MURST, funds 40% (9806241798-007, 1998–2000).

Abbreviations: BMI, Body mass index; CES-D, Center for Epidemiological Studies Depression Rating Scale; DST, dexamethasone suppression test; DST₁, 1-mg dexamethasone suppression test; HPA, hypothalamic-pituitary-adrenocortical; WHR, waist to hip ratio.

This article has been cited by other articles:

				J. D. Veldhuis, F. Roelfsema, A. Iranmanesh, B. J. Carroll, D. M. Keenan, and S. M. Pincus Basal, Pulsatile, Entropic (Patterned), and Spiky (Staccato-like) Properties of ACTH Secretion: Impact of Age, Gender, and Body Mass Index J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 4045 - 4052. [Abstract] [Full Text] [PDF]

				P. Anagnostis, V. G. Athyros, K. Tziomalos, A. Karagiannis, and D. P. Mikhailidis The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 2692 - 2701. [Abstract] [Full Text] [PDF]

				A. Melhem, S. D. Yamada, G. F. Fleming, B. Delgado, D. R. Brickley, W. Wu, M. Kocherginsky, and S. D. Conzen Administration of Glucocorticoids to Ovarian Cancer Patients Is Associated with Expression of the Anti-apoptotic Genes SGK1 and MKP1/DUSP1 in Ovarian Tissues Clin. Cancer Res., May 1, 2009; 15(9): 3196 - 3204. [Abstract] [Full Text] [PDF]

				C. Mattsson, R. M. Reynolds, K. Simonyte, T. Olsson, and B. R. Walker Combined Receptor Antagonist Stimulation of the Hypothalamic-Pituitary-Adrenal Axis Test Identifies Impaired Negative Feedback Sensitivity to Cortisol in Obese Men J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1347 - 1352. [Abstract] [Full Text] [PDF]

				D. L. Waters, C. R. Qualls, R. I. Dorin, J. D. Veldhuis, and R. N. Baumgartner Altered Growth Hormone, Cortisol, and Leptin Secretion in Healthy Elderly Persons With Sarcopenia and Mixed Body Composition Phenotypes J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2008; 63(5): 536 - 541. [Abstract] [Full Text] [PDF]

				M. Manco, J. M. Fernandez-Real, M. E. Valera-Mora, H. Dechaud, G. Nanni, V. Tondolo, M. Calvani, M. Castagneto, M. Pugeat, and G. Mingrone Massive Weight Loss Decreases Corticosteroid-Binding Globulin Levels and Increases Free Cortisol in Healthy Obese Patients: An adaptive phenomenon? Diabetes Care, June 1, 2007; 30(6): 1494 - 1500. [Abstract] [Full Text] [PDF]

				A. Bousquet-Melou, E. Formentini, N. Picard-Hagen, L. Delage, V. Laroute, and P.-L. Toutain The Adrenocorticotropin Stimulation Test: Contribution of a Physiologically Based Model Developed in Horse for Its Interpretation in Different Pathophysiological Situations Encountered in Man Endocrinology, September 1, 2006; 147(9): 4281 - 4291. [Abstract] [Full Text] [PDF]

				J. R. Seckl, N. M. Morton, K. E. Chapman, and B. R. Walker Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue Recent Prog. Horm. Res., January 1, 2004; 59(1): 359 - 393. [Abstract] [Full Text]

				R. S. Legro, H. M. Lin, L. M. Demers, and T. Lloyd Urinary Free Cortisol Increases in Adolescent Caucasian Females during Perimenarche J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 215 - 219. [Abstract] [Full Text] [PDF]